Drug dose adjustment in patients with renal impairment attending a specialized referral hospital, Northwest Ethiopia.

Drug dosage adjustment Ethiopia Renal impairment

Journal

Metabolism open
ISSN: 2589-9368
Titre abrégé: Metabol Open
Pays: England
ID NLM: 101767753

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 11 08 2022
revised: 14 09 2022
accepted: 14 09 2022
entrez: 30 9 2022
pubmed: 1 10 2022
medline: 1 10 2022
Statut: epublish

Résumé

Numerous drugs and their metabolites are removed from the body through the kidney. Improper use of drugs in renal impaired patients may therefore, be harmful and have deleterious effects. Thus, this study was aimed at investigating drug dose adjustment in renal impaired patients attending a specialized hospital. A prospective cross-sectional study was performed at the medical ward in University of Gondar comprehensive specialized hospital from March to May 2018. During the study period, a total of 2100 patients were admitted to the general medical wards. We located and assessed 210 patient files, of which 189 patient files had complete notes. Based on our inclusion criteria, 105 patients had Crcl of ≥ 59 ml per min per 1.73 m2. Therefore, 84 patients fulfilled our inclusion criteria and were included in the final analysis. The collected data were entered into Epi Info version 7 and exported to the statistical package for the social sciences (SPSS) version 20 for statistical analysis. A chi-square test was applied to test the relationship between renal status and dosage adjustment. P-value ≤ 0.05 was considered as statistical significance. Since the number of co-morbidities and number of drugs prescribed was non-normally distributed using the Shapiro-Wilk test (P < 0.001), the spearman correlation test was used (r = 0.228, p = 0.037). The mean age of study participants was 57 years with 57.1% male and 42.9% female. The highest number of renal impaired patients was in stage three 56(66.7%). The mean creatinine clearance (Crcl) was 41.8 ml/min (IQR 24.8-60.9), and the mean serum creatinine (Scr) value of 2.63 mg/dl (IQR 1.3-3.1). More than two third (76.2%) of the study participants had comorbidities. Eighty-four patients with 257 prescription entries were included in the study. Of which 75 prescription entries need a drug dose adjustment. The overall rate of inappropriate dose adjustment was 42.6% (32/75). Inappropriate dose adjustment was more common with vancomycin (14.3%) and ciprofloxacin (6%). Inappropriate drug dose adjustments were associated with patients having intermediate renal insufficiency (P < 0.002) and co-morbid conditions (P < 0.02). The present study demonstrated that inappropriate dose adjustment was common at University of Gondar comprehensive specialized hospital that needs great attention. Vancomycin and ciprofloxacin were the most frequently identified drugs that were inappropriately adjusted. Intermediate renal insufficiency and co-morbidities were statically significant with inappropriate dose adjustment.

Sections du résumé

Background UNASSIGNED
Numerous drugs and their metabolites are removed from the body through the kidney. Improper use of drugs in renal impaired patients may therefore, be harmful and have deleterious effects. Thus, this study was aimed at investigating drug dose adjustment in renal impaired patients attending a specialized hospital.
Methods UNASSIGNED
A prospective cross-sectional study was performed at the medical ward in University of Gondar comprehensive specialized hospital from March to May 2018. During the study period, a total of 2100 patients were admitted to the general medical wards. We located and assessed 210 patient files, of which 189 patient files had complete notes. Based on our inclusion criteria, 105 patients had Crcl of ≥ 59 ml per min per 1.73 m2. Therefore, 84 patients fulfilled our inclusion criteria and were included in the final analysis. The collected data were entered into Epi Info version 7 and exported to the statistical package for the social sciences (SPSS) version 20 for statistical analysis. A chi-square test was applied to test the relationship between renal status and dosage adjustment. P-value ≤ 0.05 was considered as statistical significance. Since the number of co-morbidities and number of drugs prescribed was non-normally distributed using the Shapiro-Wilk test (P < 0.001), the spearman correlation test was used (r = 0.228, p = 0.037).
Results UNASSIGNED
The mean age of study participants was 57 years with 57.1% male and 42.9% female. The highest number of renal impaired patients was in stage three 56(66.7%). The mean creatinine clearance (Crcl) was 41.8 ml/min (IQR 24.8-60.9), and the mean serum creatinine (Scr) value of 2.63 mg/dl (IQR 1.3-3.1). More than two third (76.2%) of the study participants had comorbidities. Eighty-four patients with 257 prescription entries were included in the study. Of which 75 prescription entries need a drug dose adjustment. The overall rate of inappropriate dose adjustment was 42.6% (32/75). Inappropriate dose adjustment was more common with vancomycin (14.3%) and ciprofloxacin (6%). Inappropriate drug dose adjustments were associated with patients having intermediate renal insufficiency (P < 0.002) and co-morbid conditions (P < 0.02).
Conclusion UNASSIGNED
The present study demonstrated that inappropriate dose adjustment was common at University of Gondar comprehensive specialized hospital that needs great attention. Vancomycin and ciprofloxacin were the most frequently identified drugs that were inappropriately adjusted. Intermediate renal insufficiency and co-morbidities were statically significant with inappropriate dose adjustment.

Identifiants

pubmed: 36177456
doi: 10.1016/j.metop.2022.100211
pii: S2589-9368(22)00049-4
pmc: PMC9513174
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100211

Informations de copyright

© 2022 The Authors. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

The authors’ dealer that they have no conflict of interest.

Références

JAMA. 2005 Aug 17;294(7):813-8
pubmed: 16106006
Saudi Pharm J. 2012 Jul;20(3):217-20
pubmed: 23960796
Postgrad Med J. 1998 Jul;74(873):420-2
pubmed: 9799917
Clin Pharmacokinet. 2000 Sep;39(3):185-201
pubmed: 11020134
PLoS One. 2015 Apr 17;10(4):e0124506
pubmed: 25886472
Nephron. 1976;16(1):31-41
pubmed: 1244564
Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):908-12
pubmed: 17464934
Dtsch Arztebl Int. 2010 Sep;107(37):647-55; quiz 655-6
pubmed: 20959896
Am J Kidney Dis. 1983 Nov;3(3):155-93
pubmed: 6356890
Drugs Aging. 2009;26(7):595-606
pubmed: 19655826
S Afr Med J. 2010 May 04;100(5):304-6
pubmed: 20460024
Am J Hosp Pharm. 1991 Sep;48(9):1965-9
pubmed: 1928142
Arch Intern Med. 1994 Jul 11;154(13):1511-7
pubmed: 8018007
Intern Med J. 2003 Jan-Feb;33(1-2):10-3
pubmed: 12534872
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
BMC Nephrol. 2015 Oct 07;16:158
pubmed: 26446847
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1254-60
pubmed: 16804098
Am J Med. 1977 Apr;62(4):486-9
pubmed: 851118
Am J Kidney Dis. 2009 Nov;54(5):983-4; author reply 985-6
pubmed: 19853206
J Nepal Health Res Counc. 2014 Jan;12(26):54-8
pubmed: 25574986
Am J Hosp Pharm. 1992 Dec;49(12):2944-8
pubmed: 1481798
J Gen Intern Med. 2001 Jun;16(6):369-75
pubmed: 11422633
Rev Infect Dis. 1990 Mar-Apr;12(2):236-49
pubmed: 2184494
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169

Auteurs

Mequanent Kassa Birarra (M)

Department of Clinical Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Gashaw Binega Mekonnen (GB)

Department of Clinical Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Dessalegn Asmelashe Gelayee (DA)

Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Nega Tezera Assimamaw (NT)

Department of Pediatric Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Zemene Demelash Kifle (ZD)

Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.

Classifications MeSH